Comparison

TB-500 vs Thymosin Beta-4

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

Preclinical

A synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). Unlike TB-4, TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.

HealingAnimal Studies
Thymosin Beta-4

Also: TB-4, Tβ4

Clinical Trials

The full 43-amino acid protein that TB-500 is derived from. Naturally occurring in most human tissues, TB-4 has a shorter half-life (~2 hours) compared to its synthetic fragment TB-500 (~2-4 days). Often mislabeled as 'TB-500' by vendors in premixed products.

HealingHuman Trials

Key Comparison Insights

  • Both peptides belong to the Healing category, suggesting similar primary applications.
  • Thymosin Beta-4 has stronger research evidence (Human Trials) compared to TB-500 (Animal Studies).

Detailed Comparison

AttributeTB-500Thymosin Beta-4
CategoryHealingHealing
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionTB-500 is derived from the active region of the full Thymosin Beta-4 protein. It promotes cell migration by binding to and sequestering actin, a protein essential for cell movement. It upregulates actin expression, promotes angiogenesis, reduces inflammation, and facilitates hair follicle stem cell migration for wound healing.Thymosin Beta-4 is the primary actin-sequestering protein in mammalian cells. It regulates actin polymerization, promotes cell migration, angiogenesis, and wound healing. TB-4 also has anti-inflammatory properties and promotes stem cell differentiation. The active healing region of TB-4 was isolated to create the synthetic fragment TB-500.
Common Dosing
2-2.5 mg twice weekly (loading), then 2.5 mg once weekly (maintenance)
2x weekly for 4-6 weeks, then 1x weekly
2.5-5 mg 2-3x weekly
2-3x weekly
AdministrationSubcutaneous or intramuscular injectionSubcutaneous injection, topical for eye conditions
Typical Duration4-6 weeks loading, then maintenance4-8 weeks typical protocol
Best Time to TakeMorning or eveningMorning or split doses
Possible Side Effects
May vary by individual
  • Generally well-tolerated in preclinical studies
  • Injection site reactions
  • Headache
  • Fatigue
  • Nausea
  • +5 more
  • Generally well-tolerated
  • Injection site reactions
  • Headache
  • Fatigue
  • May trigger histamine release - use caution with MCAS or histamine sensitivity
  • +3 more
Research SummaryAnimal studies show significant wound healing acceleration, cardiac tissue repair, and anti-inflammatory effects. Note: Phase 2 human trials exist for full Thymosin Beta-4 protein (not TB-500 specifically) - 73-patient venous stasis ulcer trial showed ~25% achieved complete healing at 3 months. Ophthalmologic trials for dry eye also completed. However, TB-500 fragment itself has no human clinical trials. FDA restricted TB-500 from compounding under Category 2. WADA prohibited at all times.Extensive research on wound healing, cardiac repair, and tissue regeneration. Studies show TB-4 accelerates dermal wound closure and promotes corneal epithelial healing. Research in cardiac repair shows improved outcomes post-myocardial infarction in animal models. The shorter half-life means more frequent dosing compared to TB-500.

Frequently Asked Questions: TB-500 vs Thymosin Beta-4

What is the difference between TB-500 and Thymosin Beta-4?

TB-500 is a healing peptide that a synthetic 17-amino acid fragment of thymosin beta-4 (tb-4). unlike tb-4, tb-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. note: many vendors mislabel tb-4 as 'tb-500' in premixed products. Thymosin Beta-4 is a healing peptide that the full 43-amino acid protein that tb-500 is derived from. naturally occurring in most human tissues, tb-4 has a shorter half-life (~2 hours) compared to its synthetic fragment tb-500 (~2-4 days). often mislabeled as 'tb-500' by vendors in premixed products. The main differences lie in their mechanisms of action and clinical applications.

Which is better, TB-500 or Thymosin Beta-4?

Neither is universally "better" - the choice depends on your specific goals. TB-500 is typically used for healing purposes, while Thymosin Beta-4 is used for healing. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can TB-500 and Thymosin Beta-4 be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using TB-500 and Thymosin Beta-4 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles